Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
43.31B | 40.98B | 41.95B | 41.68B | 41.17B | 36.50B | Gross Profit |
33.96B | 32.43B | 33.17B | 31.88B | 29.91B | 26.90B | EBIT |
17.43B | 17.04B | 19.03B | 17.17B | 15.07B | 13.08B | EBITDA |
19.15B | 19.27B | 21.09B | 19.04B | 16.87B | 15.02B | Net Income Common Stockholders |
12.08B | 11.64B | 13.40B | 12.16B | 10.96B | 9.29B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
97.41B | 89.85B | 80.14B | 67.15B | 56.01B | 45.41B | Total Assets |
117.38B | 109.10B | 99.46B | 86.22B | 75.40B | 64.20B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-87.41B | -84.85B | -73.14B | -62.15B | -56.01B | -42.41B | Total Liabilities |
14.84B | 15.10B | 15.78B | 14.92B | 14.33B | 13.39B | Stockholders Equity |
102.53B | 94.00B | 83.68B | 71.30B | 61.07B | 50.80B |
Cash Flow | Free Cash Flow | ||||
0.00 | 10.53B | 14.31B | 12.12B | 11.16B | 14.23B | Operating Cash Flow |
0.00 | 13.05B | 16.80B | 14.08B | 12.99B | 16.08B | Investing Cash Flow |
0.00 | -8.56B | -3.85B | -2.02B | -3.82B | 4.25B | Financing Cash Flow |
0.00 | -1.28B | -1.03B | -1.03B | -641.00M | -641.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥1.38T | 30.55 | 1.64% | 24.10% | 11.27% | ||
73 Outperform | ¥219.00B | 18.13 | 0.59% | 4.47% | -1.74% | ||
73 Outperform | €638.12B | 29.21 | 15.61% | 0.43% | 6.23% | 78.16% | |
73 Outperform | $6.12T | 27.53 | 11.70% | 0.83% | -5.48% | -11.96% | |
71 Outperform | ¥3.82T | 25.95 | 1.30% | 6.51% | -0.45% | ||
69 Neutral | $2.56T | 35.73 | 15.31% | 1.59% | 8.65% | 12.22% | |
60 Neutral | $11.39B | 10.50 | -6.42% | 2.97% | 7.77% | -11.17% |